Condition
Excision Margin
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 2 (1)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07384767Phase 2Not Yet Recruiting
Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing
NCT04827875Phase 1Completed
Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
NCT04918381Not ApplicableCompleted
CellFX Treat & Resect Low-Risk BCC Feasibility Study
NCT04344847Not ApplicableUnknownPrimary
Incidental Finding of Gastrointestinal Stromal Tumors (GISTs) During Laparoscopic Sleeve Gastrectomy, How to Deal? How Much Safety Margin
Showing all 4 trials